今年以来，以对外授权为主的BD交易带火了国产创新药市场，跨国药企巨头用真金白银验证了国产创新药的价值。仅上半年，国内创新药BD交易总额就已经达到608亿美元，超过2024年全年。除了药品，医疗器械作为临床诊疗的关键手段，也是整个医药市场的重要组成部分。在创新药BD热潮之下，不少行业人士也在问：BD的热风能否吹热医疗器械行业？

Medical device maker Becton, Dickinson and Co. is studying the feasibility of recycling syringes discarded by health care facilities and using the material to make new products.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named as one of the 100 Best Corporate Citizens of 2024 by 3BL, ranking ...

Upcoming IPO: BD Securities Limited plans to go public with an IPO, approved by NSE, to fund working capital and corporate purposes.

The U.S. Centers for Disease Control and Prevention has issued a health advisory on a shortage of plastic Becton Dickinson and Co. Bactec blood culture media bottles.

Bangladesh Finance and Investment Company Ltd (BD Finance) has signed a deal with US-based Sovereign Infrastructure Group (SIG) to attract $2 billion worth of investment in infrastructure projects ...